BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 31408876)

  • 1. Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.
    Wang C; Holtzman DM
    Neuropsychopharmacology; 2020 Jan; 45(1):104-120. PubMed ID: 31408876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease.
    Lucey BP; McCullough A; Landsness EC; Toedebusch CD; McLeland JS; Zaza AM; Fagan AM; McCue L; Xiong C; Morris JC; Benzinger TLS; Holtzman DM
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
    Nies SH; Takahashi H; Herber CS; Huttner A; Chase A; Strittmatter SM
    J Biol Chem; 2021 Oct; 297(4):101159. PubMed ID: 34480901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep-Wake Disorders in Alzheimer's Disease: A Review.
    Sun YY; Wang Z; Zhou HY; Huang HC
    ACS Chem Neurosci; 2022 May; 13(10):1467-1478. PubMed ID: 35507669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology.
    Roh JH; Huang Y; Bero AW; Kasten T; Stewart FR; Bateman RJ; Holtzman DM
    Sci Transl Med; 2012 Sep; 4(150):150ra122. PubMed ID: 22956200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocretin/Orexin, Sleep and Alzheimer's Disease.
    Dauvilliers Y
    Front Neurol Neurosci; 2021; 45():139-149. PubMed ID: 34052817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.
    Cedernaes J; Osorio RS; Varga AW; Kam K; Schiöth HB; Benedict C
    Sleep Med Rev; 2017 Feb; 31():102-111. PubMed ID: 26996255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-reported Sleep Problems Related to Amyloid Deposition in Cortical Regions with High HOMER1 Gene Expression.
    Fjell AM; Sederevicius D; Sneve MH; de Lange AG; Bråthen AC; Idland AV; Watne LO; Wang Y; Reinbold C; Dobricic V; Kilpert F; Blennow K; Zetterbergj H; Hong S; Bertram L; Walhovd KB;
    Cereb Cortex; 2020 Apr; 30(4):2144-2156. PubMed ID: 32142100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    Duncan MJ; Guerriero LE; Kohler K; Beechem LE; Gillis BD; Salisbury F; Wessel C; Wang J; Sunderam S; Bachstetter AD; O'Hara BF; Murphy MP
    Neuroscience; 2022 Jan; 481():111-122. PubMed ID: 34856352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It's complicated: The relationship between sleep and Alzheimer's disease in humans.
    Lucey BP
    Neurobiol Dis; 2020 Oct; 144():105031. PubMed ID: 32738506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.
    Morrone CD; Raghuraman R; Hussaini SA; Yu WH
    Mol Neurodegener; 2023 Apr; 18(1):27. PubMed ID: 37085942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the Inter-Relationship between Sleep Disorders and Alzheimer's Disease Pathogenesis.
    Mueed Z; Rai PK; Kamal MA; Poddar NK
    CNS Neurol Disord Drug Targets; 2021; 20(8):723-735. PubMed ID: 32885762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.
    Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H
    Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Mouse Model of Alzheimer's Disease Expressing Aβ4-42 and Human Mutant Tau.
    Zampar S; Wirths O
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian and sleep phenotypes in a mouse model of Alzheimer's disease characterized by intracellular accumulation of amyloid β oligomers.
    Sato T; Ochiishi T; Higo-Yamamoto S; Oishi K
    Exp Anim; 2024 May; 73(2):186-192. PubMed ID: 38092387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep Disturbance and Alzheimer's Disease: The Glial Connection.
    Sunkaria A; Bhardwaj S
    Neurochem Res; 2022 Jul; 47(7):1799-1815. PubMed ID: 35303225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian and sleep dysfunction in Alzheimer's disease.
    Uddin MS; Tewari D; Mamun AA; Kabir MT; Niaz K; Wahed MII; Barreto GE; Ashraf GM
    Ageing Res Rev; 2020 Jul; 60():101046. PubMed ID: 32171783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.